Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Generally very positive experience. Our management trust people who can make real contributions to the team
Was gefällt dir am besten am Führungsteam?
Our leaders care about us above the business
Was ist das Beste an Ihrem Vergütungspaket?
Stock options, Heath insurance and equity
Was sind einige der besten Dinge an Ihrem Team?
Energy and Dedication of the team
Was macht Sie bei der Arbeit am glücklichsten?
Making impact and advance career
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
Management are supportive They take a personal approach
Other Employee Reviews for Karyopharm Therapeutics
×